How should we use calcineurin inhibitors in myasthenia gravis?

E-ISSN： 1759-1961|6|2|118-119

ISSN： 1759-1961

Source： CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol.6, Iss.2, 2015-05, pp. : 118-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of myasthenia gravis patients with calcineurin inhibitors in Japan: A retrospective analysis of outcomes

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 2, 2015-05 ,pp. : 195-200

John Wiley & Sons Inc

Access to resources Recommend Favorite

What should we target? The beginning of a new era in the diagnosis and treatment of myasthenia gravis

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 1, 2015-02 ,pp. : 3-4

John Wiley & Sons Inc

Access to resources Recommend Favorite

How should we screen for breast cancer?

SIGNIFICANCE, Vol. 1740-9705, Iss. 1, 2011-03 ,pp. : 28-30

John Wiley & Sons Inc

Access to resources Recommend Favorite

Japanese clinical guidelines for myasthenia gravis: Putting into practice

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 1, 2015-02 ,pp. : 21-31

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fusion by the IHS transform: should we use cylindrical or spherical coordinates?

By Schetselaar E. M.

International Journal of Remote Sensing, Vol. 19, Iss. 4, 1998-03 ,pp. : 759-765

Taylor & Francis Ltd

Access to resources Recommend Favorite